beta-lactams has been researched along with Cross Infection in 236 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (5.08) | 18.7374 |
| 1990's | 26 (11.02) | 18.2507 |
| 2000's | 92 (38.98) | 29.6817 |
| 2010's | 98 (41.53) | 24.3611 |
| 2020's | 8 (3.39) | 2.80 |
| Authors | Studies |
|---|---|
| Ismail, D | 1 |
| Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L | 1 |
| Gormez, A; Ozgeris, B; Yildirim, M | 1 |
| Asehnoune, K; Bellouard, R; Bouras, M; Bourdiol, A; Cinotti, R; Dailly, E; Demeure Dit Latte, D; Gregoire, M; Grillot, N; Hourmant, Y; Lagarde, C; Le Floch, R; Mahe, PJ; Roquilly, A | 1 |
| Higuita-Gutiérrez, LF; Jiménez-Quiceno, JN; Vargas-Alzate, CA | 1 |
| Birckener, J; Butin-Druoton, AL; Germain, A; Guerci, P; Leon, L; Losser, MR; Luc, A; Novy, E; Pape, E; Scala-Bertola, J; Thilly, N | 1 |
| Long, SW; Lu, S; Musser, JM; Nguyen, HAT; Palzkill, T; Soeung, V | 1 |
| Fujita, S; Furuichi, K; Hara, A; Ikeo, K; Iwata, Y; Kitajima, S; Matsushima, K; Minami, T; Miyagawa, T; Nakajima, T; Ogura, H; Sakai, N; Sakai, Y; Sakai-Takemori, Y; Sato, K; Satou, K; Senda, Y; Shichino, S; Shimizu, M; Toyama, T; Ueha, S; Wada, T; Yamaguchi, K; Yamamura, Y; Yoneda, I | 1 |
| Guerci, P; Novy, E; Roger, C; Scala-Bertola, J | 1 |
| Economou, CJP; Lipman, J; McWhinney, B; Roberts, JA; Ungerer, JPJ; Wong, G | 1 |
| Kim, HS; Kim, HY; Kim, YK; Lee, J; Lee, JA; Lee, SS; Seo, YB; Song, W; Uh, Y | 1 |
| Dmitrenko, O; Gostev, V; Kalinogorskaya, O; Khokhlova, O; Kruglov, A; Lobzin, Y; Ryabchenko, I; Sidorenko, S; Yamamoto, T | 1 |
| Cheng, A; Chuang, YC; Sheng, WH; Wang, JT; Yang, JJ | 1 |
| Lutgens, SP; Mollers, M; Schneeberger, PM; Schoffelen, AF; Suijkerbuijk, AWM | 1 |
| Flach, CF; Gillings, MR; Joakim Larsson, DG; Kristiansson, E; Marathe, NP; Razavi, M | 1 |
| Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Aznar, J; Barrón-Adúriz, R; Calvo, J; Cantón, R; Castillo, FJ; Cercenado, E; Cisterna, R; González-Romo, F; López-Hontangas, JL; López-Mendoza, D; Loza, E; Molloy, B; Suárez-Barrenechea, AI; Tubau, F | 1 |
| Falagas, ME; Kapaskelis, A; Karageorgopoulos, DE; Tansarli, GS | 1 |
| Bou, G; Castelo-Corral, L; Gutiérrez-Urbón, JM; Llinares, P; López-Calviño, B; Molina, F; Sousa, D | 1 |
| Bonten, MJ; Cohen Stuart, JW; Dorigo-Zetsma, JW; Frakking, FN; Kluytmans, JA; Leverstein-van Hall, MA; Lutgens, SP; Prins, JM; Rottier, WC; Thijsen, SF; van Hattem, JM; van Hees, BC; Verbon, A; Vlaminckx, BJ | 1 |
| Badal, RE; Cao, B; Chen, M; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Y; Hu, Z; Huang, W; Kong, H; Liao, K; Lu, J; Ni, Y; Shao, H; Shen, D; Su, J; Sun, Z; Wang, H; Wang, Y; Wu, A; Xu, Y; Yang, Q; Ye, H; Yu, Y; Zhang, H; Zhang, S | 1 |
| Chang, CL; Chang, KK; Huang, YC; Lu, CM; Su, LH; Tai, FT | 1 |
| Keynan, Y; Rubinstein, E | 1 |
| Chen, H; Li, Z; Ni, M; Wang, H; Wang, Q; Wang, X; Xu, X; Yang, P; Zhao, C | 1 |
| Adrie, C; Azoulay, E; Darmon, M; Dinh-Xuan, AT; Garrouste-Orgeas, M; Jamali, S; Kallel, H; Planquette, B; Schwebel, C; Souweine, B; Timsit, JF; Vignoud, L; Zahar, JR | 1 |
| Hiraki, Y; Kawano, F; Matsui, M; Shibayama, K; Suzuki, M; Suzuki, S | 1 |
| Akashi, K; Chong, Y; Harada, Y; Kadowaki, M; Miyake, N; Shimoda, S; Shimono, N; Uchida, Y | 1 |
| Bowman, C; Charlett, A; Cookson, B; Davey, P; Fleet, E; Gopal Rao, G; Patel, B | 1 |
| Alves, M; Bige, N; Canoui, E; Offenstadt, G; Tankovic, J | 1 |
| Badal, RE; Biedenbach, DJ; Bouchillon, SK; Hackel, M; Hoban, DJ; Nga, TT; Phuong, DM; Phuong, NT; Phuong, TT | 1 |
| Alvarado, A; Carrero, G; Fajardo, C; Gómez, F; Jiménez, A | 1 |
| Ahn, C; Doi, Y; Hu, F; O'Hara, JA; Rivera, JI; Syed, A | 1 |
| John, KR; Kesavan, LM; Kumar, VA; Manoharan, A; Mathai, D; Paul, B; Sugumar, M | 1 |
| Chen, CH; Chen, JB; Chiu, CH; Chuang, FR; Lee, CT; Liu, HT; Wu, CH; Yang, CC | 1 |
| Bahador, A; Esmaeili, D; Jalalvand, N; Kholdi, S; Nasrolahei, M; Saghi, H; Zahedi, B | 1 |
| Chaubey, VP; Dalton, B; Gregson, DB; Laupland, KB; Pitout, JD; Ross, T | 1 |
| Agassounon-Djikpo Tchibozo, M; Akpovi, CD; Anago, E; Ayi-Fanou, L; Bankole, HS; Hounkpe, WB; Sanni, A | 1 |
| Hara, T; Horiyama, T; Kanazawa, S; Maki, H; Sato, T; Yamaguchi, T | 1 |
| Nordmann, P; Poirel, L; Potron, A | 1 |
| Chrischilles, EA; Dawson, JD; Diekema, DJ; Goto, M; Herwaldt, LA; Jiang, L; McDanel, JS; Perencevich, EN; Schweizer, ML; Smith, TC | 1 |
| Gorelik, AL; Karaseva, OV; Katosova, LK; Kryzhanovskaya, OA; Lazareva, AV; Mayanskiy, NA; Ponomarenko, OA | 1 |
| Anghel, A; Anghel, M; Baditoiu, L; Hogea, E; Horhat, F; Licker, M; Moldovan, R; Muntean, D; Seclaman, E; Tamas, L | 1 |
| Garritson, S; Lee, S; Lin, M; Liu, C; Nichols, A; Prasad, P | 1 |
| Abbo, LM; Rosa, R; Sfeir, M; Smith, L; Wawrzyniak, A | 1 |
| Cipolla, A; D'Abramo, A; D'Agostino, C; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Tierno, F; Trinchieri, V; Vullo, V | 1 |
| Giske, CG; Iversen, A; Nematzadeh, S; Shahcheraghi, F | 1 |
| Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Chongtrakool, P; Diraphat, P; Malathum, K; Pornsinchai, P; Siripanichgon, K | 1 |
| Arakawa, Y; Fujita, A; Jin, W; Kimura, K; Mikamo, H; Suematsu, H; Wachino, J; Yamada, K; Yamagishi, Y; Yokoyama, S | 1 |
| Cachero, A; Castellote, J; Dueñas, E; Girbau, A; Grau, I | 1 |
| Arends, JP; Deurenberg, RH; Friedrich, AW; Grundmann, H; Lo-Ten-Foe, J; Lokate, M; Raangs, EG; Rossen, JW; Tepper, M; Zhou, K | 1 |
| Cipolla, A; D'Abramo, A; De Angelis, M; Favaro, M; Ferretti, G; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Vullo, V | 1 |
| Alonso, CA; Bellaaj, R; Ben Said, L; Ben Slama, K; Boudabous, A; Chairat, S; Dziri, R; Jouini, A; Klibi, N; Torres, C | 1 |
| Manzano-García, M; Márquez-Saavedra, E | 1 |
| Nicolau, DP; Sutherland, CA; Verastegui, JE | 1 |
| Al-Hasan, MN; Ereshefsky, BJ; Gokun, Y; Martin, CA | 1 |
| Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N | 1 |
| Aguilera Rossi, CG; Ayala Serrano, JA; Gómez-Puertas, P | 1 |
| Antunes, MM; Barbosa de Castro, CMM; Barros, JF; Cabral, AB; Lopes, ACS; Maciel, MAV | 1 |
| Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P | 1 |
| Angeletti, S; Ciotti, M; Dolfa, C; Favalli, C; Sakarikou, C | 1 |
| Alouache, S; Arlet, G; Bakour, R; Benhassine, T; Gautier, V; Iabadene, H; Messai, Y; Tazir, M | 1 |
| Abrahamian, FM; Deblieux, PM; Emerman, CL; Kollef, MH; Kupersmith, E; Leeper, KV; Paterson, DL; Shorr, AF | 1 |
| Alves, AF; Cardoso, OM; Donato, AM; Leitão, R; Pena, A | 1 |
| Antonelli, M; Cambieri, A; Cataldo, MA; Cauda, R; De Pascale, G; Fadda, G; Manno, D; Sanguinetti, M; Spanu, T; Tacconelli, E | 1 |
| Berta, J; Damjanova, I; Füzi, M; Hajbel-Vékony, G; Jakab, M; Milch, H; Pászti, J; Tóth, A | 1 |
| Pascual, A; Rodríguez-Baño, J | 1 |
| Asensi, MD; Guerra, LR; Peirano, G; Pinto, MC; Seki, LM; Val Passos, VL | 1 |
| Ensor, VM; Evans, JT; Hawkey, PM; Jamal, W; Rotimi, VO | 1 |
| Herrera, ML; Jorgensen, JH; Lewis, JS; Prakash, V; Wickes, BL | 1 |
| Drusano, GL; Esposito, S; Leone, S; Lucini, V; Ma, L; Pannacci, M; Scaglione, F | 1 |
| Gudiol, F; Suárez, C | 1 |
| Amicosante, G; Celenza, G; Galleni, M; Mercuri, PS; Pellegrini, C; Perilli, M; Sacchetti, E; Segatore, B; Volpe, R | 1 |
| Dal-Paz, K; Lima, AL; Oliveira, PR; Paula, AP; Rossi, F; Zumiotti, AV | 1 |
| Bejon, P; Bowler, IC; Walker, TM | 1 |
| Bernabeu, S; Monnet, X; Nordmann, P; Poirel, L; Potron, A; Richard, C | 1 |
| Ermertcan, S; Hosgor-Limoncu, M; Tasli, H; Yurtman, AN | 1 |
| Achour, W; Ben Hassen, A; Bouchami, O | 1 |
| Falagas, ME; Karageorgopoulos, DE | 1 |
| Bonomo, RA; Casiano-Colón, AE; Depasquale, JM; Endimiani, A; Fiorella, PD; Forero, S; Hujer, AM; Kitchel, B; Perez, F; Pickens, N; Roberts-Pollack, D; Tenover, FC | 1 |
| Bindayna, KM; Botta, GA; Khanfar, HS; Senok, AC | 1 |
| Gentry, LO; Wilkinson, LD | 1 |
| Clarke, AM; Zemcov, SJ | 1 |
| Witte, W | 1 |
| Kamath, S; Mallaya, S; Shenoy, S | 1 |
| Muir, A; Weinbren, MJ | 1 |
| Cantón, R; Coque, TM; del Campo, R; Martín, O; Morosini, MI; Rodríguez-Baños, M; Rodríguez-Domínguez, M; Valverde, A | 1 |
| Chen, BY; Chu, YZ; Nian, H; Shang, H; Sun, GQ; Tian, SF | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Oreshkina, TD | 1 |
| Dogra, V; Loomba, P; Mishra, B; Taneja, J; Thakur, A | 1 |
| Chu, CC; Hsueh, PR; Huang, YT; Lai, CC; Lee, PI; Lee, YL; Lu, CL; Tan, CK; Wang, CY | 1 |
| Ferraro, MJ; Hooper, DC; Hyle, EP; Lee, H; Silver, M | 1 |
| Bishara, J; Leibovici, L; Lev, B; Lishtzinsky, Y; Paul, M; Samra, Z; Talker, O; Zemer-Wassercug, N | 1 |
| Evdokimov, A; Han, S; Lacey, BM; Marr, ES; Miller, JR; Shanmugasundaram, V; Tomaras, AP; Zaniewski, RP | 1 |
| Cai, J; Liu, J; Wu, D | 1 |
| Corona, D; Gona, F; Mezzatesta, ML; Scriffignano, V; Stefani, S; Veroux, M; Veroux, P; Zerbo, D | 1 |
| Chung, JK; Dong, F; Graber, CJ; Hutchings, C; Lee, W; Tran, T | 1 |
| Brouse, SD; Cooper, TW; Hall, RG; Pass, SE | 1 |
| Alvarez-Rivera, E; Castro-Orozco, R; De Arco, MM; Rambaut-Donado, CL; Villafañe-Ferrer, LM; Vitola-Heins, GV | 1 |
| Gastal, SL; Goldani, LZ; Gorniak Lovatto, C; Jacoby, T; Konkewicz, L; Kuplich, NM; Lisboa, T; Nagel, FM; Pires dos Santos, R; Pires Machado, D; Pires, MR | 1 |
| Hammami, A; Ktari, S; Louati, F; Mahjoubi, F; Mezghani, S; Mnif, B; Rekik, S | 1 |
| Espinal, P; Roca, I; Vila, J | 1 |
| Bhattacharjee, A; Ranjan Sen, M; Seema, K; Upadhyay, S | 1 |
| Iyer, S; Maharjan, S; Perry, C; Pike, R; Stacey, A; Virgincar, N; Woodford, N; Wyeth, J | 1 |
| Bordon, JM; Clark, RB; Karlowsky, JA; Master, RN; Ramirez, J | 1 |
| Adams-Haduch, JM; Bogdanovich, T; Doi, Y; Kwak, EJ; Muto, CA; Nguyen, MH; Tian, GB | 1 |
| Cook, PP; Gooch, M; Rizzo, S | 1 |
| Amicosante, G; Celenza, G; Luzzaro, F; Mugnaioli, C; Perilli, M; Pini, B; Rossolini, GM; Segatore, B; Stefani, S | 1 |
| Abdelali, S; Abdelouahid, DE; Azzaoui, H; Rahmoun, M; Rebiahi, SA | 1 |
| Giakkoupi, P; Papagiannitsis, CC; Pappa, O; Polemis, M; Tryfinopoulou, K; Tzelepi, E; Tzouvelekis, LS; Vatopoulos, AC | 1 |
| Caniça, M; Diogo, J; Ferreira, E; Jones-Dias, D; Louro, D; Manageiro, V; Pinto, M | 1 |
| Bourigault, C; Caroff, N; Corvec, S; Crémet, L; Guillouzouic, A; Juvin, ME; Lepelletier, D; Reynaud, A | 1 |
| An, D; Chong, Y; Chung, HS; Kim, MN; Lee, K; Woo, JH; Yong, D | 1 |
| Borde, J; de With, K; Kern, WV; Stocker, H | 1 |
| Abreu-Lanfranco, O; Bhargava, P; Bheemreddy, S; Blunden, C; Carmeli, Y; Chopra, T; Chugh, N; Collins, VL; Eiseler, S; Hayakawa, K; Kaye, KS; Lephart, PR; Marchaim, D; Memon, BI; Moshos, J; Munoz-Price, LS; Pogue, JM; Shallal, A; Sunkara, B | 1 |
| Heizmann, P; Heizmann, WR; Lode, H | 1 |
| Rice, LB | 1 |
| Cuzon, G; Demachy, MC; Naas, T; Nordmann, P | 1 |
| Cai, Y; Kwa, AL; Lee, W; Tan, TT; Tan, TY; Tang, S; Teo, J | 1 |
| Aleo, A; Bonura, C; Brunelli, T; Degl'Innocenti, R; Fasciana, T; Mammina, C; Nastasi, A; Pesavento, G | 1 |
| Aumeran, C; Forestier, C; Hennequin, C; Robin, F; Traore, O | 1 |
| Hsueh, PR | 1 |
| Aschenbrenner, LM; Fahnoe, KC; Finegan, SM; Lacey, BM; Lemmon, MM; McPherson, CJ; Mueller, JP; O'Donnell, JP; Tadakamalla, B; Tomaras, AP | 1 |
| Brhelova, E; Cizek, A; Dobiasova, H; Dolejska, M; Dubska, L; Jurankova, J; Krivdova, J; Kutnikova, L; Literak, I; Sevcikova, A; Sterba, J; Vavrina, M | 1 |
| Artigas, A; Díaz-Martín, A; Ferrer, R; Garnacho-Montero, J; Levy, MM; Lopez-Pueyo, MJ; Martín-Loeches, I; Martínez-González, ML; Ortiz-Leyba, C; Piacentini, E | 1 |
| Cordero-Laurent, E; Gamboa-Coronado, MM; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E | 1 |
| Abaev, I; Dyatlov, I; Fursova, N; Kartsev, N; Kruglov, A; Pecherskikh, E; Pryamchuk, S; Svetoch, E | 1 |
| Banerjee, R; Enthaler, N; Fernandez, MG; Graml, C; Greenwood-Quaintance, KE; Patel, R | 1 |
| Arnold, HM; Hampton, NB; Hoban, A; Hoffmann, J; Hollands, JM; Juang, PH; Kollef, MH; McCormick, S; Micek, ST; Reichley, RM; Skrupky, LP; Smith, JR | 1 |
| Ahmed, S; Hameed, A; Hasan, F; Shah, AA | 1 |
| Berthel, M; Heitz, D; Jehl, F; Kaltenbach, G; Kiesmann, M; Kuntzmann, F; Martin-Hunyadi, C; Noblet-Dick, M; Vogel, T | 1 |
| Amicosante, G; Colì, A; Docquier, JD; Lombardi, G; Luzzaro, F; Perilli, M; Riccio, ML; Rossolini, GM; Toniolo, A | 1 |
| Wang, F; Xiong, Z; Zhang, Y; Zhu, D | 1 |
| Peña, C; Pujol, M | 1 |
| Isaacs, RD; Shah, PM | 1 |
| Karpov, OI; Strekachev, AIu; Zaĭtsev, AA | 1 |
| Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M | 1 |
| Agnifili, A; Amicosante, G; Franceschini, N; Franchino, L; Perilli, M; Rossolini, GM; Segatore, B; Setacci, D | 1 |
| Arakawa, Y; Doi, Y; Ito, H; Kubota, T; Shibata, N; Wachino, J; Yagi, T; Yamane, K | 1 |
| Calvo, F; Canduela, MJ; Gallego, L; Martín, G; Pujana, I; Sevillano, E; Umaran, A | 1 |
| Ardito, F; Blandino, G; Fadda, G; Fontana, R; Lo Cascio, G; Marchese, A; Marchetti, F; Nicoletti, G; Schito, GC | 1 |
| Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W | 1 |
| Dzierzanowska, D; Kamińska, W | 1 |
| Han, L; Jiang, X; Jiang, Y; Li, M; Liu, H; Lu, Y; Ni, Y; Yang, L; Yuan, F | 1 |
| Campillos, P; Cebrián, L; Gonzalo-Jiménez, N; López-Lozano, JM; Rodríguez-Díaz, JC; Royo, G; Yagüe, A | 1 |
| Bonfiglio, G; Lanzafame, A; Mattina, R; Santini, L | 1 |
| de Morais Júnior, MA; de Souza Lopes, AC; Falcão Rodrigues, J | 1 |
| Carmeli, Y; Navon-Venezia, S; Schwaber, MJ; Schwartz, D | 1 |
| Coyle, EA; Melnick, DA; Schilling, AN; Tam, VH | 1 |
| Gemmell, CG; Hall, V; Smith, AJ; Thakker, B | 1 |
| Daoud, Z; Doucet-Populaire, F; Hakimé, NI; Hamzé, M; Mangeney, N; Matta, H; Mokhbat, JE; Moubareck, C; Rohban, R; Sarkis, DK | 1 |
| Bodmann, KF | 1 |
| Chen, WH; Hsueh, PR; Luh, KT | 1 |
| Lolans, K; Quinn, JP; Suárez, CJ; Villegas, MV | 1 |
| Al-Sweih, N; Noronha, B; Udo, EE | 1 |
| Almela, M; Brugal, MT; Castro, P; Caylà, JA; Coll, P; Colomés, JLL; de la Red, G; de Olalla, PG; Español, M; García, F; Gatell, JM; Libois, A; March, F; Romeu, J; Salvadó, M; Sambeat, MA; Sánchez, F; Sierra, JM; Vila, J | 1 |
| Ewig, S; Ostendorf, U; Torres, A | 1 |
| Barth, AL; Fernandes, JF; Gaspareto, PB; Goldani, LZ; Gonçalves, AL; Moro, AL; Zavascki, AP | 1 |
| Hanaki, H; Hayashi, I; Hososaka, Y; Iwata, S; Matsui, H; Nakae, T; Sunakawa, K; Yamaguchi, Y; Yanagisawa, C | 1 |
| Falagas, ME; Horianopoulou, M; Kanellopoulou, M; Lambropoulos, S; Legakis, NJ; Tsakris, A | 1 |
| Adeyi, B; DiNubile, MJ; Friedland, IR; Ginanni, JA; McCarroll, KA; Stratchounski, LS; Wood, CA; Woods, GL; Yakovlev, SV | 1 |
| Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK | 1 |
| Drusano, GL; Lodise, TP; Lomaestro, B | 1 |
| García-Rodríguez, JA; Muñoz Bellido, JL | 1 |
| DeRyke, CA; Kuti, JL; Nicolau, DP | 1 |
| Falagas, ME; Manta, KG; Siempos, II; Vardakas, KZ | 1 |
| Chatterjee, I; Iredell, JR; Lipman, J; Woods, M | 1 |
| Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A | 1 |
| Markova, B; Marteva-Proevska, Y; Mitov, I; Ouzounova-Raykova, V; Strateva, T; Todorova, A | 1 |
| Huang, SS; Lee, N; Lee, SC; See, LC; Shieh, WB; Tsai, MH | 1 |
| Bauer, F; Benca, J; Grey, E; Huttova, M; Kovac, M; Ondrusova, A; Rudinsky, B; Sramka, M | 1 |
| Bauer, F; Benca, J; Beno, P; Huttova, M; Kisac, P; Kovac, M; Ondrusova, A; Rudinsky, B; Sramka, M | 1 |
| Bhat, S; Capitano, B; Fujitani, S; Linden, PK; Paterson, DL; Potoski, BA; Shutt, K | 1 |
| Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y | 1 |
| Abramson, MA; Doern, GV; Eagye, KJ; Gallagher, G; Lockhart, SR; Nicolau, DP; Quinn, JP | 1 |
| Beloborodov, VB; Eliseeva, EV; Grigor'ev, KB; Iakovlev, SV; Iakovlev, VP; Kon, EM; Kostina, GV; Kuprenkov, AV; Levit, AL; Mukhacheva, SIu; Saturnov, AV; Sergeev, IN; Sidorenko, SV; Spasov, GP; Stakanov, AV; Ushakova, MA | 1 |
| Yoshida, A | 1 |
| Nieradko, J | 1 |
| Joseph, J; Rodvold, KA | 1 |
| Hirakata, Y; Kamihira, S; Kohno, S; Matsuda, J; Morinaga, Y; Motoshima, M; Sugahara, K; Yamada, Y; Yamamoto, K; Yanagihara, K | 1 |
| Ammari, H; Arlet, G; Bakour, R; Iabadene, H; Lounes, S; Messai, Y; Ramdani-Bouguessa, N | 1 |
| Berçot, B; Fihman, V; Jacquier, H; Lartigue, MF; Meunier, F; Raskine, L; Riahi, J; Sanson-le Pors, MJ; Schnepf, N | 1 |
| Chen, HE; Cheng, KC; Chuang, YC; Ko, WC; Lee, CC; Yu, WL | 1 |
| Baraniak, A; Empel, J; Fiett, J; Gniadkowski, M; Hryniewicz, W; Literacka, E; Mrówka, A; Sadowy, E | 1 |
| Neu, HC | 1 |
| Edelstein, PH; Meyer, RD; Pasiecznik, KA; Yasui, VK | 1 |
| Bakkouch, A; Duault, M; Dupeyron, C; Leluan, G; Louarn, F; Mangeney, N; Niel, P; Pons, JL; Royan, F | 1 |
| Kahr, A; Michéa-Hamzehpour, M; Pechère, JC | 1 |
| Godard, C; Hannecart-Pokorni, E; Hubrechts, JM; Maes, P; Nulens, E; Nyssen, HJ; Vanhoof, R; Wildemauwe, C | 1 |
| Hu, BS; Lau, YJ; Lin, YH; Liu, PY; Shi, ZY; Shyr, JM; Tsai, WS; Tseng, CY | 1 |
| Kazmierczak, A; Lopez, J; Neuwirth, C; Pechinot, A; Siebor, E | 1 |
| Cheng, K; Denning, N; Doherty, C; Govan, JR; Hart, CA; Heaf, DP; Smyth, RL; van Saene, H; Winstanley, C | 1 |
| French, GL; Shannon, KP; Simmons, N | 1 |
| Bailey, EM; Hart, SM | 1 |
| Brownlee, KG; Conway, SP; Denton, M; Littlewood, JM; Todd, NJ | 1 |
| Biddle, JW; Culver, DH; Edwards, JR; Gaynes, RP; Martone, WJ; Monnet, DL; Tenover, FC; Tolson, JS | 1 |
| Husson, MO; Izard, D; Monteil, H; Ross, P; Scheftel, JM; Vachée, A | 1 |
| Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R | 1 |
| Williams, D | 1 |
| Ardanuy, C; Ariza, J; Gudiol, F; Liñares, J; Pallares, R; Peña, C; Pujol, M; Ricart, A | 1 |
| Rokosz, A; Sawicka-Grzelak, A | 1 |
| Barcs, I; Rozgonyi, F; Szabó, D | 1 |
| Doern, GV; Erwin, ME; Hollis, RJ; Jones, RN; Pfaller, MA | 1 |
| Jones, RN | 1 |
| Chang, BJ; McGregor, K; Mee, BJ; Riley, TV | 1 |
| Hall, LM; Livermore, DM; Savelkoul, PH; Vandenbroucke-Grauls, CM; Yuan, M | 1 |
| Amyes, SG; Gulay, Z; Thomson, CJ; Yulug, N | 1 |
| Davis, GA; Rapp, RP | 1 |
| Bolsoni, AP; Mendes, RE; Roland, RK; Sader, HS; Silbert, S | 1 |
| Fennewald, M; Girlich, D; Karim, A; Leelaporn, A; Nordmann, P; Poirel, L; Tribuddharat, C | 1 |
| Andre, C; Arpin, C; Dubois, V; Frigo, C; Melon, B; Melon, M; Quentin, C | 1 |
| Aihara, M; Ikeda, N; Kinoshita, S; Komatsu, M; Nakamachi, Y; Shimakawa, K; Yamasaki, K | 1 |
| Inoue, M | 1 |
| Maniatis, AN; Polyzou, A; Pournaras, S; Slavakis, A; Sofianou, D; Tsakris, A | 1 |
| Rahal, JJ | 1 |
| Aguilar, C; Becerra, Z; Echániz, G; Garza-Ramos, U; Gatica, R; Leaños, B; Miranda, G; Silva, J; Solórzano, F; Velázquez, M | 1 |
| Kocazeybek, BS | 1 |
| De Champs, C; Nordmann, P; Poirel, L; Weldhagen, GF | 1 |
| Allouch, P; Chardon, H; Chiche, D; Didion, J; Jurin, F; Pina, P; Rio, Y | 1 |
| Dajani, AS | 1 |
| Akova, M | 1 |
| Steffee, CH; Wasilauskas, BL | 1 |
| Sanders, CC; Sanders, WE | 2 |
| Friedman, BA; Pierson, CL | 1 |
| Duma, RJ; Jones, RN; McGowan, JE; Neu, HC; O'Brien, TF; Sabath, LD; Sanders, CC; Schaffner, W; Tenover, FC; Young, LS | 1 |
| Kukulianskiĭ, AA; Rimzha, MI; Sokolovskaia, AD; Suchshevich, VV | 1 |
| Arlet, G; Fournier, G; Marie, O; Philippon, A; Rouveau, M; Sanson-le Pors, MJ; Schlemmer, B | 1 |
| Ernst, F; Lenoir, L; Michel-Briand, Y; Van der Auwera, P | 1 |
| Acar, JF; Gutmann, L; Kitzis, MD | 1 |
| Almdahl, SM; Andersen, BM; George, R; Gilfillian, A; Hotvedt, R; Olafsen, K; Sørlie, D | 1 |
| Kobayashi, T; Mizuguchi, Y; Tanabe, T; Yoshida, S | 1 |
| Croize, J; Le Noc, D; Le Noc, P | 1 |
| Mansford, KR; Slocombe, B | 1 |
| Aulicino, TM; Gombert, ME | 1 |
| Foresti, I; Gelmi, M; Pirali, F; Ravizzola, G; Turano, A | 1 |
34 review(s) available for beta-lactams and Cross Infection
| Article | Year |
|---|---|
Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospital Costs; Humans; Methicillin-Resistant Staphylococcus aureus | 2013 |
Vancomycin-resistant enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2013 |
Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2015 |
Health care-associated pneumonia: identification and initial management in the ED.
Topics: Acetamides; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Emergency Treatment; Ertapenem; Female; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Patient Care Team; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Respiration, Artificial; Risk Factors; Severity of Illness Index; Tigecycline | 2008 |
Clinical significance of extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors | 2008 |
[Beta-lactam antibiotics].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; Bacteriolysis; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cell Wall; Cross Infection; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Gastrointestinal Diseases; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Organ Specificity; Spain | 2009 |
Extended-spectrum beta-lactamase-producing organisms.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2009 |
Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?
Topics: Bacterial Toxins; Bacterial Typing Techniques; beta-Lactams; Community-Acquired Infections; Cross Infection; DNA Fingerprinting; Europe; Exotoxins; Genotype; Humans; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; North America; Risk Factors; Staphylococcal Infections; Virulence Factors | 2009 |
Can Pharmacokinetic and Pharmacodynamic Principles Be Applied to the Treatment of Multidrug-Resistant Acinetobacter?
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Polymyxins; Tetracyclines | 2011 |
[Antibiotics: new and old drugs, rational prescription].
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Biological Availability; Cephalosporins; Colistin; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Practice Patterns, Physicians' | 2012 |
Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Clinical Trials as Topic; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Glycopeptides; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2012 |
Ertapenem, the first of a new group of carbapenems.
Topics: Animals; beta-Lactams; Carbapenems; Clinical Trials as Topic; Cross Infection; Ertapenem; Humans; Lactams | 2003 |
[New approaches to antibacterial therapy of infections in the surgical practice].
Topics: Abdominal Abscess; Aza Compounds; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Cross Infection; Ertapenem; Fluoroquinolones; Humans; Lactams; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Surgical Wound Infection | 2003 |
Appropriate use of the carbapenems.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections | 2004 |
[Antimicrobial drug resistant pathogens in nosocomial urinary tract infections--selected aspects].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Humans; Infection Control; Poland; Risk Factors; Urinary Tract Infections | 2004 |
Current guidelines for the treatment of severe pneumonia and sepsis.
Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Resistance; Germany; Humans; Intensive Care Units; International Cooperation; Pneumonia; Practice Guidelines as Topic; Sepsis; Severity of Illness Index | 2005 |
Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2005 |
Nosocomial pneumonia.
Topics: Aminoglycosides; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Pneumonia, Bacterial | 2006 |
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aminoglycosides; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Humans; Immunocompetence; Intensive Care Units; Meropenem; Pneumonia, Bacterial; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiration, Artificial; Survival Rate; Thienamycins; Treatment Outcome | 2007 |
The implications of enterococci for the intensive care unit.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Infection Control; Intensive Care Units; Peritonitis; Risk Factors; Vancomycin | 2007 |
[Attention-getting cross infections: Extended-spectrum beta-lactamase-producing bacterial infections].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Proteus; Proteus Infections | 2007 |
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome | 2008 |
Changing patterns of hospital infections: implications for therapy. Changing mechanisms of bacterial resistance.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Chromosomes, Bacterial; Cross Infection; DNA Transposable Elements; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Protein Binding; R Factors; Receptors, Drug | 1984 |
A practical look at the clinical usefulness of the beta-lactam/beta-lactamase inhibitor combinations.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cross Infection; Drug Therapy, Combination; Enzyme Inhibitors; Humans | 1996 |
Extended-spectrum beta-lactamases: an actual problem of hospital microbiology (a review).
Topics: Aminohydrolases; Anti-Bacterial Agents; Bacillus; Bacteria; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Gram-Negative Aerobic Rods and Cocci; Gram-Negative Anaerobic Bacteria; Gram-Positive Endospore-Forming Rods; Plasmids; Point Mutation | 1997 |
Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.
Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Humans | 1998 |
Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Otitis Media; Respiratory Tract Infections | 1998 |
Extended-spectrum beta-lactamases: how big is the problem?
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Risk Factors | 2000 |
Beta-lactam resistance: clinical implications for pediatric patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Child; Community-Acquired Infections; Cross Infection; Humans; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus | 2002 |
Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Cross Infection; Drug Therapy, Combination; Humans; Pneumonia, Bacterial | 2002 |
beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Escherichia coli; Global Health; Gram-Negative Bacteria; Haemophilus influenzae; Humans; Moraxella catarrhalis; Mutation; Neisseria; Prevalence; Pseudomonas aeruginosa; Xanthomonas | 1992 |
Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistance.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Penicillinase | 1992 |
The incidence of beta-lactamase-producing pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Humans | 1989 |
Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Humans; Microbial Sensitivity Tests; Mutation; Porins | 1985 |
5 trial(s) available for beta-lactams and Cross Infection
| Article | Year |
|---|---|
Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Republic of Korea; Tazobactam; Urinary Tract Infections | 2017 |
Impact of implementation of a novel antimicrobial stewardship tool on antibiotic use in nursing homes: a prospective cluster randomized control pilot study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Female; Humans; Inappropriate Prescribing; Long-Term Care; Male; Nursing Homes; Pilot Projects; Practice Patterns, Physicians'; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Infectious; Soft Tissue Infections; Urinary Tract Infections | 2014 |
Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Teaching; Hospitals, Urban; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Male; Meropenem; Middle Aged; Missouri; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2013 |
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Skilled Nursing Facilities | 2006 |
[Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Costs and Cost Analysis; Cross Infection; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Meropenem; Metronidazole; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Russia; Thienamycins; Treatment Outcome | 2006 |
197 other study(ies) available for beta-lactams and Cross Infection
| Article | Year |
|---|---|
Cost of antibiotics in medical intensive care.
Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Critical Care; Cross Infection; Drug Utilization; Humans; Retrospective Studies | 2022 |
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections | 2022 |
Substituted phenethylamine-based β-lactam derivatives: Antimicrobial, anticancer, and β-lactamase inhibitory properties.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Caco-2 Cells; Colorectal Neoplasms; Cross Infection; Humans; Microbial Sensitivity Tests; Phenethylamines | 2022 |
A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections-a monocentre quality improvement project.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Cross Infection; Hospitals; Humans; Quality Improvement | 2023 |
Direct medical costs of urinary tract infections by Gram-negative bacilli resistant to beta-lactams in a tertiary care hospital in Medellín, Colombia
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; Cohort Studies; Colombia; Cross Infection; Diagnostic Imaging; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Health Expenditures; Hospitalization; Hospitals, Urban; Humans; Male; Middle Aged; Tertiary Care Centers; Urinary Tract Infections | 2019 |
Serum and peritoneal exudate concentrations after high doses of β-lactams in critically ill patients with severe intra-abdominal infections: an observational prospective study.
Topics: Aged; Ascitic Fluid; beta-Lactams; Critical Illness; Cross Infection; Dose-Response Relationship, Drug; Female; France; Humans; Intraabdominal Infections; Male; Middle Aged; Peritonitis; Prospective Studies | 2020 |
Development and Evaluation of a Novel Protein-Based Assay for Specific Detection of KPC β-Lactamases from Klebsiella pneumoniae Clinical Isolates.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biological Assay; Biosensing Techniques; Colorimetry; Cross Infection; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Protein Binding; Reproducibility of Results | 2020 |
The increased frequency of methicillin-resistant Staphylococcus aureus with low MIC of beta-lactam antibiotics isolated from hospitalized patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Japan; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Mutation; Prevalence; Protein Structure, Tertiary; Staphylococcal Infections; Whole Genome Sequencing | 2020 |
Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Betacoronavirus; Cefepime; Coinfection; Confusion; Coronavirus Infections; COVID-19; Critical Illness; Cross Infection; Deep Sedation; Delirium; Drug Monitoring; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pandemics; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Sepsis | 2020 |
Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Critical Care; Critical Illness; Cross Infection; Drug Monitoring; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Renal Replacement Therapy; Retrospective Studies; Tertiary Care Centers; Young Adult | 2017 |
Molecular epidemiology and antibiotic resistance of methicillin-resistant Staphylococcus aureus circulating in the Russian Federation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Chloramphenicol; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Russia; Staphylococcal Infections; Tetracyclines | 2017 |
Impact of broad-spectrum antimicrobial treatment on the ecology of intestinal flora.
Topics: Acinetobacter baumannii; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Feces; Female; Fluoroquinolones; Gastrointestinal Microbiome; Humans; Male; Microbial Viability; Middle Aged; Moxifloxacin; Pseudomonas aeruginosa; Taiwan | 2018 |
Cost of Nosocomial Outbreak Caused by NDM-1-Containing Klebsiella pneumoniae in the Netherlands, October 2015-January 2016.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carrier State; Cost of Illness; Cross Infection; Disease Outbreaks; Gene Expression; Hospitals; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Netherlands; Plasmids | 2017 |
Discovery of the fourth mobile sulfonamide resistance gene.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Bioprospecting; Cross Infection; Dihydropteroate Synthase; Drug Resistance, Microbial; Escherichia coli; Genes, Bacterial; Humans; India; Integrons; Metagenomics; Microbial Consortia; Microbial Sensitivity Tests; Rivers; RNA, Ribosomal, 16S; Sulfonamides | 2017 |
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015).
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Combinations; Ertapenem; Escherichia coli; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Spain | 2018 |
Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Utilization; Ecosystem; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Retrospective Studies; Selection, Genetic; Tertiary Care Centers | 2013 |
Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Comorbidity; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome | 2013 |
A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China.
Topics: Anti-Bacterial Agents; beta-Lactams; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence | 2013 |
Outbreak of ertapenem-resistant Enterobacter cloacae urinary tract infections due to a contaminated ureteroscope.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; Disinfection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genes, Bacterial; Genotype; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Sequence Analysis, DNA; Taiwan; Ureteroscopes; Urinary Tract Infections | 2013 |
An outbreak of a nosocomial NDM-1-producing Klebsiella pneumoniae ST147 at a teaching hospital in mainland China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Plasmids | 2014 |
Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; France; Humans; Intensive Care Units; Macrolides; Male; Middle Aged; Multivariate Analysis; Pneumonia, Bacterial; Prospective Studies; Risk Assessment; Survival Analysis; Time Factors | 2013 |
A subclass B3 metallo-β-lactamase found in Pseudomonas alcaligenes.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cluster Analysis; Cross Infection; Genotype; Humans; Microbial Sensitivity Tests; Pseudomonas alcaligenes; Pseudomonas Infections; Sequence Analysis, DNA | 2014 |
Nosocomial spread of meticillin-resistant Staphylococcus aureus with β-lactam-inducible arbekacin resistance.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Dibekacin; DNA Transposable Elements; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Molecular Sequence Data; Molecular Typing; Sequence Analysis, DNA; Staphylococcal Infections; Transcriptional Activation | 2014 |
Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Substrate Specificity | 2014 |
Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011).
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Vietnam | 2014 |
[Risk factors associated with the isolation of extended spectrum betalactamases producing Escherichia coli or Klebsiella pneumoniae in a tertiary care hospital in Colombia].
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Case-Control Studies; Colombia; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2014 |
Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital system.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genotype; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Pennsylvania; Plasmids; Young Adult | 2014 |
Fecal carriage rates of extended-spectrum β-lactamase-producing Escherichia coli among antibiotic naive healthy human volunteers.
Topics: Adult; Anti-Bacterial Agents; Asymptomatic Diseases; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carrier State; Clone Cells; Community-Acquired Infections; Cross Infection; Disease Reservoirs; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Humans; India; Prevalence; Rural Population | 2015 |
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2014 |
Distribution of bla(OXA-23), ISAba , Aminoglycosides resistant genes among burned & ICU patients in Tehran and Sari, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Burns; Critical Illness; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Intensive Care Units; Iran; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2014 |
Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region.
Topics: Adult; Aged; Alberta; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cohort Studies; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Population Surveillance | 2014 |
Antibiotic resistance and genotype of beta-lactamase producing Escherichia coli in nosocomial infections in Cotonou, Benin.
Topics: Anti-Bacterial Agents; Benin; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Microbial Sensitivity Tests | 2015 |
Mechanism of resistance and antibacterial susceptibility in extended-spectrum β-lactamase phenotype Klebsiella pneumoniae and Klebsiella oxytoca isolated between 2000 and 2010 in Japan.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; DNA, Bacterial; Humans; Japan; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2015 |
Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin | 2015 |
[Monitoring and antibiotic resistance profile of tracheal aspirate microbiota in ICU children with severe craniocerebral trauma].
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Child; Colistin; Craniocerebral Trauma; Cross Infection; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Gene Expression; Humans; Intensive Care Units, Pediatric; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections; Trachea; Trauma Severity Indices | 2014 |
Genotype-phenotype correlation in multiresistant Escherichia coli and Klebsiella pneumoniae strains isolated in Western Romania.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Genetic Association Studies; Genotype; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Prospective Studies; Romania | 2015 |
Ertapenem Prophylaxis Associated With an Increased Risk of Clostridium difficile Infection Among Surgical Patients.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Ertapenem; Female; Hospitalization; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Postoperative Complications; Retrospective Studies; Risk Factors | 2015 |
Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cross Infection; Echocardiography; Female; Florida; Hospital Mortality; Hospitals, Teaching; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2016 |
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sepsis; Thienamycins | 2016 |
Successful international clones of blaCTX-M-15-producing Klebsiella pneumoniae with coexpression of plasmid-mediated quinolone resistance (PMQR) determinants in Tehran hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cluster Analysis; Cross Infection; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Molecular Typing; Plasmids; Quinolones | 2015 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Plasmids; Thailand; Thienamycins; Young Adult | 2015 |
Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Japan; Klebsiella Infections; Klebsiella oxytoca; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Penicillanic Acid; Piperacillin; Tazobactam | 2015 |
Ertapenem failure as therapy for nosocomial spontaneous bacterial peritonitis.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Substitution; Ertapenem; Escherichia coli; Escherichia coli Infections; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Peritonitis; Postoperative Complications; Treatment Failure | 2016 |
Use of whole-genome sequencing to trace, control and characterize the regional expansion of extended-spectrum β-lactamase producing ST15 Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clone Cells; Cross Infection; Disease Outbreaks; Gene Expression; High-Throughput Nucleotide Sequencing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multiplex Polymerase Chain Reaction; Netherlands; Patient Identification Systems; Public Health Surveillance; Virulence | 2016 |
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney Transplantation; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Surgical Wound Infection; Thienamycins | 2016 |
Detection of CTX-M-15-Producing Escherichia coli Isolates of Lineages ST131-B2 and ST167-A in Environmental Samples of a Tunisian Hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Fomites; Gene Expression; Hospitals; Humans; Integrons; Male; Microbial Sensitivity Tests; Phylogeny; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Skin; Tunisia; Virulence Factors | 2016 |
[Adequacy of treatment with ertapenem according to the criterion approved for the infection´s commission of a specialty hospital].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Ertapenem; Female; Guideline Adherence; Hospitals; Humans; Inappropriate Prescribing; Internal Medicine; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult | 2016 |
In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2016 |
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Critical Illness; Cross Infection; Drug Therapy, Combination; Female; Fluoroquinolones; Gentamicins; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Proportional Hazards Models; Retrospective Studies; Tobramycin; Treatment Outcome | 2017 |
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam | 2016 |
In vivo functional and molecular characterization of the Penicillin-Binding Protein 4 (DacB) of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Carboxypeptidases; Cefoxitin; Cross Infection; DNA, Bacterial; Endopeptidases; Enzyme Activation; Escherichia coli; Escherichia coli Proteins; Models, Molecular; Penicillin-Binding Proteins; Peptidoglycan; Pseudomonas aeruginosa; Recombinant Proteins | 2016 |
Clonal spread and accumulation of β-lactam resistance determinants in Enterobacter aerogenes and Enterobacter cloacae complex isolates from infection and colonization in patients at a public hospital in Recife, Pernambuco, Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Brazil; Cross Infection; DNA, Bacterial; Enterobacter aerogenes; Enterobacter cloacae; Hospitals, Public; Humans; Microbial Sensitivity Tests; Sequence Analysis, DNA | 2017 |
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections | 2017 |
Rapid detection of carbapenemase-producing Klebsiella pneumoniae strains derived from blood cultures by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS).
Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Blood Culture; Cell Culture Techniques; Cross Infection; Enterobacteriaceae; Ertapenem; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Laboratories; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2017 |
Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria).
Topics: Algeria; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Polymerase Chain Reaction; Prevalence; Substrate Specificity | 2008 |
Detection of Pseudomonas aeruginosa producing metallo-beta-lactamase VIM-2 in a central hospital from Portugal.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Hospitals; Humans; Microbial Sensitivity Tests; Portugal; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Catheters, Indwelling; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Methicillin Resistance; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Staphylococcal Infections | 2008 |
Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Ciprofloxacin; Cluster Analysis; Conjugation, Genetic; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Hungary; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Plasmids; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA | 2008 |
Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Brazil; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2009 |
Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Kuwait | 2009 |
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Fosfomycin; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Outpatients; Urinary Tract Infections | 2009 |
Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; beta-Lactams; Cross Infection; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Time Factors; Treatment Outcome | 2009 |
Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Cross Infection; DNA, Bacterial; Enzyme Inhibitors; Gene Order; Humans; Inhibitory Concentration 50; Isoelectric Point; Italy; Kinetics; Molecular Sequence Data; Molecular Weight; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pseudomonas Infections; Sequence Analysis, DNA; Water Microbiology | 2009 |
The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study.
Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Brazil; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
Risk factors for recurrence after Staphylococcus aureus bacteraemia. A retrospective matched case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Catheter-Related Infections; Catheterization, Central Venous; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Female; Glycopeptides; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Young Adult | 2009 |
Nosocomial spread of ESBL-positive Enterobacter cloacae co-expressing plasmid-mediated quinolone resistance Qnr determinants in one hospital in France.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; France; Genes, Bacterial; Hospitals; Humans; Plasmids; Quinolones | 2009 |
Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Synergism; Drug Therapy, Combination; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2008 |
Typing of staphylococcal cassette chromosome mec encoding methicillin resistance in Staphylococcus aureus strains isolated at the bone marrow transplant centre of Tunisia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactams; Chromosomes, Bacterial; Cluster Analysis; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals; Humans; Interspersed Repetitive Sequences; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Penicillin-Binding Proteins; Polymerase Chain Reaction; Staphylococcal Infections; Tunisia | 2009 |
Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Female; Florida; Hospitals; Humans; Immunoblotting; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Sequence Analysis, DNA | 2009 |
Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Saudi Arabia; Young Adult | 2009 |
In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Aerobic Bacteria; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 1981 |
In-vitro activity of ceftazidime compared with other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Aerobic Bacteria; Gram-Negative Bacteria; Microbial Sensitivity Tests | 1981 |
Nosocomial infections in neonatal intensive care units: profile, risk factor assessment and antibiogram.
Topics: Anti-Infective Agents; beta-Lactams; Cohort Studies; Cross Infection; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Prevalence; Risk Factors; Sepsis | 2010 |
New Delhi metallo-beta-lactamase: a cautionary tale.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; India; Microbial Sensitivity Tests | 2010 |
Population analysis and epidemiological features of inhibitor-resistant-TEM-beta-lactamase-producing Escherichia coli isolates from both community and hospital settings in Madrid, Spain.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids; Sequence Analysis, DNA; Spain | 2010 |
Pharmacokinetic-pharmacodynamic profiling of four antimicrobials against gram-negative bacteria collected from Shenyang, China.
Topics: Anti-Bacterial Agents; beta-Lactams; China; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2010 |
[Dynamics of acquires resistance in the main gramnegative pathogens of surgical infections to beta-lactams in 2004-2008].
Topics: beta-Lactam Resistance; beta-Lactams; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Postoperative Complications; Retrospective Studies; Russia | 2010 |
Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis; Tetracycline | 2010 |
Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Enterococcus; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Staphylococcus aureus; Taiwan; Teicoplanin; Vancomycin | 2011 |
Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Boston; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Ertapenem; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome; Urban Population; Young Adult | 2010 |
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?
Topics: Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; beta-Lactams; Cross Infection; Drug Combinations; Drug Evaluation; Female; Humans; Logistic Models; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2011 |
Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa.
Topics: Amino Acids, Aromatic; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Crystallography, X-Ray; Humans; Models, Molecular; Penicillin-Binding Proteins; Protein Structure, Tertiary; Pseudomonas aeruginosa; Pseudomonas Infections; Siderophores | 2010 |
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
Topics: Age Factors; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Thienamycins | 2011 |
Klebsiella pneumoniae ESBL producers responsible for severe UTIs in a renal transplant unit.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Urinary Tract Infections | 2011 |
Changes in antibiotic usage and susceptibility in nosocomial Enterobacteriaceae and Pseudomonas isolates following the introduction of ertapenem to hospital formulary.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Prescriptions; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Pseudomonas; Regression Analysis | 2012 |
[Methicillin-resistant Staphylococcus aureus in children attending school in Cartagena, Colombia].
Topics: Anti-Bacterial Agents; beta-Lactams; Carrier State; Child; Child, Preschool; Colombia; Community-Acquired Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nasal Cavity; Risk; Staphylococcal Infections; Superinfection | 2010 |
Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cross Infection; Ertapenem; Hand Disinfection; Hospitals, University; Humans; Incidence; Pseudomonas aeruginosa; Pseudomonas Infections; Regression Analysis | 2011 |
Spread of Klebsiella pneumoniae isolates producing OXA-48 β-lactamase in a Tunisian university hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Cross Infection; Gene Transfer, Horizontal; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tunisia | 2011 |
Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Species Specificity | 2011 |
Dissemination of the New Delhi metallo-β-lactamase-1 (NDM-1) among Enterobacteriaceae in a tertiary referral hospital in north India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; India; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Random Amplified Polymorphic DNA Technique; Young Adult | 2011 |
Klebsiella pneumoniae producing KPC carbapenemase in a district general hospital in the UK.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, General; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Typing; Polymerase Chain Reaction; Sequence Analysis, DNA; United Kingdom | 2011 |
Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Databases, Factual; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2011 |
Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Epidemics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2011 |
Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; Formularies, Hospital as Topic; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; North Carolina; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 2011 |
Persistence of TEM-52/TEM-92 and SHV-12 extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in Italy.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Italy; Microbial Sensitivity Tests | 2011 |
Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
Topics: Adult; Aged; Algeria; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Fosfomycin; Gentamicins; Hospitals, University; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Rifampin; Staphylococcal Infections; Surgical Wound Infection; Vancomycin; Vancomycin Resistance | 2011 |
Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Greece; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing | 2012 |
Emergence and risk factors of β-lactamase-mediated resistance to oxyimino-β-lactams in Enterobacteriaceae isolates.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Young Adult | 2012 |
Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Gastrointestinal Tract; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests | 2012 |
Nosocomial clustering of NDM-1-producing Klebsiella pneumoniae sequence type 340 strains in four patients at a South Korean tertiary care hospital.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cluster Analysis; Cross Infection; Disk Diffusion Antimicrobial Tests; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Republic of Korea | 2012 |
Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2012 |
[Is monotherapy with β-lactam antibiotics still up to date? New aspects for treatment of severe infections].
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cell Wall; Critical Care; Cross Infection; Drug Therapy, Combination; Exotoxins; Guideline Adherence; Humans; Immunization; Interleukin-8; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Virulence Factors | 2012 |
Nosocomial outbreak of Klebsiella pneumoniae harbouring bla(KPC-3) in France subsequent to a patient transfer from Italy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; France; Genotype; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Patient Transfer; Plasmids | 2012 |
Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Logistic Models; Male; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Risk Factors; Singapore; Treatment Outcome; Young Adult | 2012 |
Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2012 |
Antibiotic resistance and plasmid transfer capacity in biofilm formed with a CTX-M-15-producing Klebsiella pneumoniae isolate.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Biofilms; Cross Infection; Disease Outbreaks; France; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2012 |
Study for Monitoring Antimicrobial Resistance Trends (SMART) in the Asia-Pacific region, 2002-2010.
Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Global Health; Humans; Microbial Sensitivity Tests | 2012 |
Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam.
Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Blotting, Western; Cloning, Molecular; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gene Library; Gram-Negative Bacteria; Mice; Porins; Pseudomonas aeruginosa; Sepsis; Siderophores | 2012 |
Dissemination of IncFII(K)-type plasmids in multiresistant CTX-M-15-producing Enterobacteriaceae isolates from children in hospital paediatric oncology wards.
Topics: Adolescent; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Cluster Analysis; Cross Infection; Czech Republic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Fluoroquinolones; Genotype; Hospitals, Pediatric; Humans; Multilocus Sequence Typing; Neoplasms; Plasmids | 2012 |
Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality.
Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Practice Patterns, Physicians'; Sepsis; Shock, Septic; Spain; Treatment Outcome | 2012 |
Resistance of Bacteroides isolates recovered among clinical samples from a major Costa Rican hospital between 2000 and 2008 to ß-lactams, clindamycin, metronidazole, and chloramphenicol.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides Infections; beta-Lactam Resistance; beta-Lactams; Chloramphenicol; Clindamycin; Costa Rica; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies | 2012 |
The novel CTX-M-116 β-lactamase gene discovered in Proteus mirabilis is composed of parts of the CTX-M-22 and CTX-M-23 genes.
Topics: Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Databases, Nucleic Acid; Escherichia coli; Escherichia coli Proteins; Humans; Molecular Sequence Data; Protein Isoforms; Proteus Infections; Proteus mirabilis; Recombination, Genetic; Sequence Homology, Nucleic Acid | 2013 |
Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus.
Topics: beta-Lactams; Cefoxitin; Community-Acquired Infections; Cross Infection; Drug Synergism; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2013 |
Extended-spectrum beta-lactamases in Enterobacteriaceae: related to age and gender.
Topics: Adult; Age Factors; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Pakistan; Sex Factors | 2002 |
[Urinary tract infections due to wide spectrum beta lactamase producing enterobacteriaceae].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Geriatrics; Hospital Departments; Humans; Length of Stay; Male; Recurrence; Survival Rate; Treatment Failure; Urinary Tract Infections | 2002 |
Nosocomial infections caused by multidrug-resistant isolates of pseudomonas putida producing VIM-1 metallo-beta-lactamase.
Topics: Aged; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Integrons; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Pseudomonas Infections; Pseudomonas putida; Urinary Tract Infections | 2002 |
[Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Escherichia coli; Humans; Inhibitory Concentration 50; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence | 2002 |
[The clinical significance of broad-spectrum beta-lactamases].
Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence | 2003 |
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections | 2004 |
Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta-lactamase patterns including extended-spectrum enzymes.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Colony Count, Microbial; Cross Infection; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Sequence Analysis, DNA; Thienamycins | 2004 |
Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
Topics: Amino Acid Sequence; beta-Lactamases; beta-Lactams; Blotting, Southern; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant, Newborn; Intensive Care, Neonatal; Isoelectric Focusing; Japan; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
[Carbapenemase detection in Acinetobacter baumannii clones resistant to imipenem].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Multicenter Studies as Topic; Spain; Thienamycins | 2004 |
Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Humans; Italy; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus | 2004 |
Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China.
Topics: Amino Acid Sequence; beta-Lactamases; beta-Lactams; China; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2005 |
[Expanded-spectrum beta-lactamase-producing strains of E. coli: origin, characteristics and incidence in Southern Alicante (Spain) in the period 1999-2003].
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Hospitals, General; Hospitals, University; Humans; Incidence; Inpatients; Outpatients; Spain | 2005 |
In vitro activity of levofloxacin against recent Gram-negative nosocomial pathogens.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2005 |
Molecular typing of Klebsiella pneumoniae isolates from public hospitals in Recife, Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Brazil; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Hospitals, Public; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Random Amplified Polymorphic DNA Technique | 2005 |
High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae.
Topics: beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Microbial Sensitivity Tests; Plasmids | 2005 |
Comparison of beta-lactams in counter-selecting resistance of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Electrophoresis, Polyacrylamide Gel; Humans; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents.
Topics: Actinomyces; Actinomycosis; Anti-Bacterial Agents; beta-Lactams; Cross Infection; DNA, Bacterial; DNA, Ribosomal; Humans; Microbial Sensitivity Tests; RNA, Bacterial; RNA, Ribosomal, 16S | 2005 |
Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Lebanon; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2005 |
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan | 2005 |
Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; beta-Lactams; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterotoxins; Exotoxins; Genes, Bacterial; Hospitals; Humans; Kuwait; Leukocidins; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Recombinases; Staphylococcal Infections; Staphylococcus aureus; Urease | 2006 |
Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003.
Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Middle Aged; Molecular Epidemiology; Mutation; Population Surveillance; Prospective Studies; Restriction Mapping; Retrospective Studies; Risk Factors; Sequence Analysis, DNA; Soft Tissue Infections; Spain; Streptococcal Infections; Streptococcus pyogenes; Substance Abuse, Intravenous | 2006 |
Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Case-Control Studies; Cross Infection; Female; Fluoroquinolones; Hospitals, Teaching; Humans; Incidence; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2006 |
Nosocomial infection of beta-lactam antibiotic-induced vancomycin-resistant Staphylococcus aureus (BIVR).
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2006 |
Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit.
Topics: Acute Disease; beta-Lactamases; beta-Lactams; Bronchi; Carbapenems; Carrier State; Cross Infection; Female; Genes, Bacterial; Gram-Negative Bacteria; Greece; Hospitals, General; Humans; Intensive Care Units; Male; Middle Aged; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Time Factors; Trachea; Urban Population | 2006 |
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical | 2006 |
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; beta-Lactams; Cohort Studies; Critical Illness; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Retrospective Studies | 2007 |
[Do we have adequate antimicrobials against methicillin-resistant Staphylococcus aureus?].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cross Infection; Drug Design; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Europe; Humans; Methicillin Resistance; Penicillin-Binding Proteins; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2006 |
Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactams; Cross Infection; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2007 |
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests | 2007 |
Widespread detection of VEB-1-type extended-spectrum beta-lactamases among nosocomial ceftazidime-resistant Pseudomonas aeruginosa isolates in Sofia, Bulgaria.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Bulgaria; Cephalosporin Resistance; Cross Infection; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacterial Infections; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests | 2007 |
Is combination therapy with betalactam plus aminoglycoside (AGL) improving the outcome of nosocomial meningitis in children?
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Therapy, Combination; Glycopeptides; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Prognosis; Retrospective Studies; Treatment Outcome | 2007 |
Insufficient therapy for nosocomial meningitis negatively affects survival, sequellae and has social consequences.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Retrospective Studies; Treatment Failure; Vancomycin | 2007 |
Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Topics: Algorithms; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Intensive Care Units; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors | 2007 |
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA | 2007 |
A pharmacodynamic analysis of resistance trends in pathogens from patients with infection in intensive care units in the United States between 1993 and 2004.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; United States | 2007 |
[Estimation of the contribution of the small plasmids in creation of ESBL phenotype among clinical and ambulatory isolates of the Enterobacteriaceae].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; F Factor; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2007 |
Quantitative detection of metallo-beta-lactamase of blaIMP-cluster-producing Pseudomonas aeruginosa by real-time polymerase chain reaction with melting curve analysis for rapid diagnosis and treatment of nosocomial infection.
Topics: beta-Lactamases; beta-Lactams; Cross Infection; DNA Gyrase; Humans; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity | 2008 |
Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria.
Topics: Algeria; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA | 2008 |
Appearance of aac(6')-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; France; Gene Expression Regulation, Bacterial; Genes, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests | 2008 |
Institutional spread of clonally related Serratia marcescens isolates with a novel AmpC cephalosporinase (S4): a 4-year experience in Taiwan.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blood; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Molecular Epidemiology; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Serratia Infections; Serratia marcescens; Taiwan | 2008 |
Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Data Collection; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Molecular Epidemiology; Molecular Sequence Data; Poland | 2008 |
Susceptibility of Legionella sp. and nosocomial respiratory tract isolates of Enterobacteriaceae to Sch 29482 and other beta-lactam agents.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Enterobacteriaceae; Humans; Lactams; Legionella; Microbial Sensitivity Tests; Respiratory Tract Infections | 1982 |
[Outbreak of infections of Klebsiella pneumoniae with extended spectrum beta-lactamase in a hospital unit with a long and medium stay].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Case-Control Studies; Cross Infection; Disease Outbreaks; Electrophoresis, Polyacrylamide Gel; France; Hospital Units; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 1995 |
In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Evaluation Studies as Topic; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Infection Control; Risk Factors | 1994 |
Serotypes and extended spectrum beta-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study.
Topics: Amikacin; Anti-Bacterial Agents; Belgium; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Gentamicins; Hospitals; Humans; Pseudomonas aeruginosa; Serotyping | 1993 |
Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests | 1995 |
Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Chromosomes, Bacterial; Cross Infection; Disease Outbreaks; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; France; Genotype; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction | 1996 |
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Cross Infection; Cystic Fibrosis; DNA Fingerprinting; Drug Resistance, Microbial; Genotype; Humans; Infant; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sputum | 1996 |
Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; London | 1996 |
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis unit.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Cystic Fibrosis; England; Humans; Outpatient Clinics, Hospital; Pseudomonas aeruginosa; Pseudomonas Infections | 1996 |
Evidence of interhospital transmission of extended-spectrum beta-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. The National Nosocomial Infections Surveillance System.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; DNA, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Population Surveillance; Regression Analysis; United States | 1997 |
[Tricentric study of the sensitivity of Pseudomonas aeruginosa serotyping to beta-lactams and aminoglycosides].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Serotyping | 1997 |
Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic | 1997 |
[Resistance to beta-lactams].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; Cross Infection; Gene Expression Regulation, Enzymologic; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Penicillin Resistance; United Kingdom | 1997 |
Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Intensive Care Units; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Risk Factors | 1998 |
[Susceptibility of clinical strains of gram-negative rods to selected beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Species Specificity | 1997 |
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Gram-Negative Aerobic Rods and Cocci; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Humans | 1998 |
SHV-13, a novel extended-spectrum beta-lactamase, in Klebsiella pneumoniae isolates from patients in an intensive care unit in Amsterdam.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; DNA Fingerprinting; Intensive Care Units, Neonatal; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Netherlands; Plasmids; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction | 2000 |
High prevalence of extended spectrum beta-lactamase production among Klebsiella pneumoniae strains isolated at a University Hospital in Turkey.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence; Turkey | 2000 |
Comparison of five beta-lactam antibiotics against common nosocomial pathogens using the time above MIC at different creatinine clearances--a comment.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Humans; Microbial Sensitivity Tests | 2000 |
In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
Topics: Bacteria; Bacterial Infections; beta-Lactams; Brazil; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Hospitals, University; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2000 |
Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ceftazidime; Conjugation, Genetic; Cross Infection; Electroporation; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Humans; Integrases; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Polymerase Chain Reaction; Thailand | 2001 |
Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.
Topics: Adult; Amikacin; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Ribotyping | 2001 |
Hospital outbreak of MEN-1-derived extended spectrum beta-lactamase-producing Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Polymerase Chain Reaction | 2001 |
Hospital outbreak of MEN-1-derived extended spectrum beta-lactamase-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Genotype; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction | 2001 |
Predominance of a methicillin-resistant Staphylococcus aureus clone susceptible to erythromycin and several other non-beta-lactam antibiotics in a Greek hospital.
Topics: Anti-Bacterial Agents; beta-Lactams; Clone Cells; Cross Infection; Erythromycin; Greece; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 2001 |
Outbreak of infection with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Mexican hospital.
Topics: Bacteremia; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Mexico; Microbial Sensitivity Tests | 2001 |
Antimicrobial resistance surveillance of gram-negative bacteria isolated from intensive care units of four different hospitals in Turkey. Evaluation of the prevalence of extended-spectrum and inducible beta-lactamases using different E-test strips and dir
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Data Collection; Drug Resistance, Multiple; Gram-Negative Bacteria; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Prevalence; Turkey | 2001 |
A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum beta-lactamase GES-2 in South Africa.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ceftazidime; Cross Infection; Disease Outbreaks; DNA, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Mutagenesis, Insertional; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Random Amplified Polymorphic DNA Technique; South Africa | 2002 |
[Susceptibility of Pseudomonas aeruginosa to antibiotics isolated from patients of intensive care units in France in 1998. Resistant phenotypes to beta-lactams].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; France; Humans; Intensive Care Units; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections | 2002 |
Beta-lactamase expression and cross-resistance to beta-lactam antibiotics in a nosocomial population of Enterobacter.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacter cloacae; Enterobacteriaceae Infections; Microbial Sensitivity Tests; Species Specificity | 1992 |
Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Chromatography, Gas; Cross Infection; Drug Resistance, Microbial; Fatty Acids; Humans; Intensive Care Units; Michigan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum | 1992 |
[Resistance of hospital Staphylococci to beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Staphylococcus aureus | 1991 |
Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Humans; Intensive Care Units; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Paris; R Factors; Respiratory System; Risk Factors; Sepsis; Surgical Wound Infection; Urinary Tract | 1990 |
In-vitro susceptibility pattern and characterization of resistance in Pseudomonas aeruginosa serotype O12 isolated in Belgium in 1986.
Topics: Anti-Bacterial Agents; Belgium; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Species Specificity | 1990 |
Multiply beta-lactam resistant Enterobacter cloacae infections linked to the environmental flora in a unit for cardiothoracic and vascular surgery.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Cardiac Surgical Procedures; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Departments; Humans; Male; Middle Aged; Operating Rooms; Sepsis; Serotyping; Surgery Department, Hospital; Surgical Wound Infection; Vascular Surgical Procedures | 1989 |
[Susceptibility of gram-negative bacterial isolates to six beta-lactam and two aminoglycoside antibiotics at our university hospital].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans | 1988 |
[Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cross Infection; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 1987 |
The evolution of antibiotic production and public health problems.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Humans | 1987 |
Amikacin synergism with beta-lactam antibiotics against selected nosocomial pathogens.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Humans; Kanamycin; Microbial Sensitivity Tests | 1986 |
Resistance to beta-lactam antibacterial agents in hospitals.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Humans; Pseudomonas; R Factors; Staphylococcus aureus | 1985 |